Skip to main content
logo
CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.370
-0.190 (-4.17%)
Apr 2, 2026, 1:44 PM EDT - Market open

CytomX Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
94572583114106283
Market Cap Growth
1851.85%778.75%-27.88%7.96%-62.58%-10.41%
Enterprise Value
839.99587.94-13.88-50.72-73.71-4.02
Last Close Price
4.374.261.031.551.604.33
PE Ratio
--28.402.71-155.00-1.06-2.39
Forward PE
---16.30--
PS Ratio
12.779.510.601.131.997.59
PB Ratio
7.847.32-180.93-2.41-1.24-616.89
P/TBV Ratio
6.035.94-191.42-2.41-1.23-605.13
P/FCF Ratio
--9.56-0.95-2.01-0.94-2.35
P/OCF Ratio
--9.59-0.96-2.04-0.96-2.38
EV/Sales Ratio
11.027.72-0.10-0.50-1.39-0.11
EV/EBITDA Ratio
--28.01-0.5211.770.750.04
EV/EBIT Ratio
--26.29-0.567.820.730.03
EV/FCF Ratio
--7.760.160.890.660.03
Debt / Equity Ratio
-0-9.30-0.20-0.16-39.34
Debt / EBITDA Ratio
-0.20-0.200.35-3.24-0.18-0.16
Debt / FCF Ratio
-0.06-0.06-0.11-0.25-0.16-0.15
Net Debt / Equity Ratio
-1.34-1.34200.083.382.05625.64
Net Debt / EBITDA Ratio
6.336.33-3.4137.261.782.53
Net Debt / FCF Ratio
1.751.751.052.821.562.38
Asset Turnover
0.560.560.860.440.180.11
Quick Ratio
2.982.981.211.141.503.93
Current Ratio
3.093.091.251.171.553.98
Return on Equity (ROE)
-35.25%-35.25%-133.06%0.85%230.41%2814.77%
Return on Assets (ROA)
-16.67%-16.67%15.40%0.48%-33.76%-33.25%
Return on Invested Capital (ROIC)
-824.52%-824.54%337.46%4.61%-546.09%-1703.99%
Return on Capital Employed (ROCE)
-32.02%-32.01%61.99%-8.41%-54.80%-42.04%
Earnings Yield
-2.09%-3.52%36.89%-0.65%-94.38%-41.80%
FCF Yield
-7.79%-10.46%-104.89%-49.71%-106.19%-42.61%
Buyback Yield / Dilution
-62.77%-62.77%-14.82%-12.27%-2.48%-39.01%
Total Shareholder Return
-62.77%-62.77%-14.82%-12.27%-2.48%-39.01%
Updated Mar 16, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q